MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
University of Maryland, Baltimore
Baltimore, Estados UnidosUniversity of Maryland, Baltimore-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2011
-
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
Blood, Vol. 117, Núm. 12, pp. 3294-3301